Meropenem

NDC 63323-507 · Fresenius Kabi USA, LLC

FDA carries 3 listing records for this NDC; the most recent is shown.

Generic nameMeropenem

Dosage formINJECTION, POWDER, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)MEROPENEM

Strength500 mg/10mL

Pharmacologic classCarbapenems [CS], Penem Antibacterial [EPC]

Marketing categoryANDA

Packages

63323-507-21 — 10 VIAL in 1 CARTON (63323-507-21) / 10 mL in 1 VIAL (63323-507-19)

63323-507-25 — 25 VIAL in 1 CARTON (63323-507-25) / 10 mL in 1 VIAL (63323-507-43)

63323-507-20 — 10 VIAL in 1 CARTON (63323-507-20) / 10 mL in 1 VIAL (63323-507-01)

J2185 — Injection, meropenem, 100 mg Medicare Part B payment limit (ASP + 6%): $0.33

FDA lists these products with the same active ingredient.

44567-146 — Meropenem, 44567-400 — Meropenem, 44567-401 — Meropenem, 44567-402 — Meropenem, 44647-032 — MEROPENEM, 44647-033 — MEROPENEM, 51810-502 — Meropenem, 51810-503 — Meropenem, 55150-207 — Meropenem, 55150-208 — Meropenem, 63323-508 — Meropenem, 68001-323 — Meropenem, 68001-324 — Meropenem, 68083-146 — Meropenem, 68083-147 — Meropenem, 70121-1453 — Meropenem, 70121-1454 — Meropenem, 70594-075 — MEROPENEM, 70594-076 — MEROPENEM, 70842-120 — Meropenem-Vaborbactam, +23 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.